APO Research
Talk to an analyst

APO RESEARCH · REPORT

Sevoflurane

Sevoflurane Source (Sevoflurane) is a halogenated general inhalation anesthetic drug. It’s a volatile liquid for inhalation, a nonflammable and nonexplosive liquid administered by vaporization.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Sevoflurane Source (Sevoflurane) is a halogenated general inhalation anesthetic drug. It’s a volatile liquid for inhalation, a nonflammable and nonexplosive liquid administered by vaporization.

In this report, one unit is 250 ml Sevoflurane.

Selected research

Industry Growth & Trends

Global Sevoflurane Industry Growth and Trends Forecast to 2032

26 December 202595 pages

Choose your research edition.

Industry ResearchSevoflurane Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Sevoflurane Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Sevoflurane Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Sevoflurane Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Sevoflurane Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

Sevoflurane Source (Sevoflurane) is a halogenated general inhalation anesthetic drug. It’s a volatile liquid for inhalation, a nonflammable and nonexplosive liquid administered by vaporization.

In this report, one unit is 250 ml Sevoflurane.

Europe is the largest Sevoflurane market with about 40% market share. Asia is follower, accounting for about 25% market share.

Read the full market overview

The key players are Abbott, Baxter, Maruishi, Jiangsu Hengrui, Lunan etc. Top 3 companies occupied about 63% market share.

Report Scope

This report provides a structured, data-driven view of the global Sevoflurane market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Sevoflurane market size, estimates, and forecasts are presented in terms of sales volume (K t) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Sevoflurane market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Sevoflurane.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Sevoflurane market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Sevoflurane Market by Company

Abbott

Baxter

Maruishi

Jiangsu Hengrui

Lunan

Sevoflurane Segment by Type

Generic Drug

Original Drug

Sevoflurane Segment by Application

Hospitals

Other Medical Institutions

Sevoflurane Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sevoflurane market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sevoflurane and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sevoflurane.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Sevoflurane manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Sevoflurane in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Generic Drug Table 2. Major Company of Original Drug Table 3. Global Sevoflurane Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Sevoflurane Sales by Type (2021-2026) & (K t) Table 5. Global Sevoflurane Sales Market Share in Volume by Type (2021-2026) Table 6. Global Sevoflurane Sales by Type (2021-2026) & (US$ Million) Table 7. Global Sevoflurane Sales Market Share in Value by Type (2021-2026) Table 8. Global Sevoflurane Price by Type (2021-2026) & (USD/Unit) Table 9. Global Sevoflurane Sales by Type (2027-2032) & (K t) Table 10. Global Sevoflurane Sales Market Share in Volume by Type (2027-2032) Table 11. Global Sevoflurane Sales by Type (2027-2032) & (US$ Million) Table 12. Global Sevoflurane Sales Market Share in Value by Type (2027-2032) Table 13. Global Sevoflurane Price by Type (2027-2032) & (USD/Unit) Table 14. North America Sevoflurane Sales by Type (2021-2026) & (K t) Table 15. North America Sevoflurane Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Sevoflurane Sales by Type (2021-2026) & (K t) Table 17. Europe Sevoflurane Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Sevoflurane Sales by Type (2021-2026) & (K t) Table 19. Asia-Pacific Sevoflurane Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Sevoflurane Sales by Type (2021-2026) & (K t) Table 21. Latin America Sevoflurane Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Sevoflurane Sales by Type (2021-2026) & (K t) Table 23. Middle East and Africa Sevoflurane Sales by Type (2021-2026) & (US$ Million) Table 24. Sevoflurane Industry Trends Table 25. Sevoflurane Industry Drivers Table 26. Sevoflurane Industry Opportunities and Challenges Table 27. Sevoflurane Industry Restraints Table 28. Global Sevoflurane Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Sevoflurane Revenue Market Share by Company (2021-2026) Table 30. Global Sevoflurane Sales by Company (2021-2026) & (K t) Table 31. Global Sevoflurane Sales Share by Company (2021-2026) Table 32. Global Sevoflurane Market Price by Company (2021-2026) & (USD/Unit) Table 33. Global Sevoflurane Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Sevoflurane Major Company Production Sites and Headquarters Table 35. Global Sevoflurane Company, Product Type & Application Table 36. Global Sevoflurane Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Sevoflurane by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Sevoflurane Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Sevoflurane Sales by Region (2021-2026) & (K t) Table 41. Global Sevoflurane Sales Market Share in Volume by Region (2021-2026) Table 42. Global Sevoflurane Sales by Region (2021-2026) & (US$ Million) Table 43. Global Sevoflurane Sales Market Share in Value by Region (2021-2026) Table 44. Global Sevoflurane Sales (K t), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 45. Global Sevoflurane Sales by Region (2027-2032) & (K t) Table 46. Global Sevoflurane Sales Market Share in Volume by Region (2027-2032) Table 47. Global Sevoflurane Sales by Region (2027-2032) & (US$ Million) Table 48. Global Sevoflurane Sales Market Share in Value by Region (2027-2032) Table 49. Global Sevoflurane Sales (K t), Value (US$ Million), Price (USD/Unit) and Gross Margin (2027-2032) Table 50. Global Sevoflurane Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Sevoflurane Sales by Application (2021-2026) & (K t) Table 52. Global Sevoflurane Sales Market Share in Volume by Application (2021-2026) Table 53. Global Sevoflurane Sales by Application (2021-2026) & (US$ Million) Table 54. Global Sevoflurane Sales Market Share in Value by Application (2021-2026) Table 55. Global Sevoflurane Price by Application (2021-2026) & (USD/Unit) Table 56. Global Sevoflurane Sales by Application (2027-2032) & (K t) Table 57. Global Sevoflurane Sales Market Share in Volume by Application (2027-2032) Table 58. Global Sevoflurane Sales by Application (2027-2032) & (US$ Million) Table 59. Global Sevoflurane Sales Market Share in Value by Application (2027-2032) Table 60. Global Sevoflurane Price by Application (2027-2032) & (USD/Unit) Table 61. North America Sevoflurane Sales by Application (2021-2026) & (K t) Table 62. North America Sevoflurane Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Sevoflurane Sales by Application (2021-2026) & (K t) Table 64. Europe Sevoflurane Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Sevoflurane Sales by Application (2021-2026) & (K t) Table 66. Asia-Pacific Sevoflurane Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Sevoflurane Sales by Application (2021-2026) & (K t) Table 68. Latin America Sevoflurane Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Sevoflurane Sales by Application (2021-2026) & (K t) Table 70. Middle East and Africa Sevoflurane Sales by Application (2021-2026) & (US$ Million) Table 71. Abbott Company Information Table 72. Abbott Business Overview Table 73. Abbott Sevoflurane Sales (K t), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 74. Abbott Sevoflurane Product Portfolio Table 75. Abbott Recent Development Table 76. Baxter Company Information Table 77. Baxter Business Overview Table 78. Baxter Sevoflurane Sales (K t), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 79. Baxter Sevoflurane Product Portfolio Table 80. Baxter Recent Development Table 81. Maruishi Company Information Table 82. Maruishi Business Overview Table 83. Maruishi Sevoflurane Sales (K t), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 84. Maruishi Sevoflurane Product Portfolio Table 85. Maruishi Recent Development Table 86. Jiangsu Hengrui Company Information Table 87. Jiangsu Hengrui Business Overview Table 88. Jiangsu Hengrui Sevoflurane Sales (K t), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 89. Jiangsu Hengrui Sevoflurane Product Portfolio Table 90. Jiangsu Hengrui Recent Development Table 91. Lunan Company Information Table 92. Lunan Business Overview Table 93. Lunan Sevoflurane Sales (K t), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 94. Lunan Sevoflurane Product Portfolio Table 95. Lunan Recent Development Table 96. North America Sevoflurane Market Size Growth Rate (CAGR) by Country (K t): 2021 VS 2025 VS 2032 Table 97. North America Sevoflurane Sales by Country (2021-2026) & (K t) Table 98. North America Sevoflurane Sales Market Share by Country (2021-2026) Table 99. North America Sevoflurane Sales Forecast by Country (2027-2032) & (K t) Table 100. North America Sevoflurane Sales Market Share Forecast by Country (2027-2032) Table 101. North America Sevoflurane Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 102. North America Sevoflurane Market Size by Country (2021-2026) & (US$ Million) Table 103. North America Sevoflurane Market Share by Country (2021-2026) Table 104. North America Sevoflurane Market Size Forecast by Country (2027-2032) & (US$ Million) Table 105. North America Sevoflurane Market Share Forecast by Country (2027-2032) Table 106. Europe Sevoflurane Market Size Growth Rate (CAGR) by Country (K t): 2021 VS 2025 VS 2032 Table 107. Europe Sevoflurane Sales by Country (2021-2026) & (K t) Table 108. Europe Sevoflurane Sales Market Share by Country (2021-2026) Table 109. Europe Sevoflurane Sales Forecast by Country (2027-2032) & (K t) Table 110. Europe Sevoflurane Sales Market Share Forecast by Country (2027-2032) Table 111. Europe Sevoflurane Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. Europe Sevoflurane Market Size by Country (2021-2026) & (US$ Million) Table 113. Europe Sevoflurane Market Share by Country (2021-2026) Table 114. Europe Sevoflurane Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. Europe Sevoflurane Market Share Forecast by Country (2027-2032) Table 116. Asia-Pacific Sevoflurane Market Size Growth Rate (CAGR) by Country (K t): 2021 VS 2025 VS 2032 Table 117. Asia-Pacific Sevoflurane Sales by Country (2021-2026) & (K t) Table 118. Asia-Pacific Sevoflurane Sales Market Share by Country (2021-2026) Table 119. Asia-Pacific Sevoflurane Sales Forecast by Country (2027-2032) & (K t) Table 120. Asia-Pacific Sevoflurane Sales Market Share Forecast by Country (2027-2032) Table 121. Asia-Pacific Sevoflurane Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Asia-Pacific Sevoflurane Market Size by Country (2021-2026) & (US$ Million) Table 123. Asia-Pacific Sevoflurane Market Share by Country (2021-2026) Table 124. Asia-Pacific Sevoflurane Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Asia-Pacific Sevoflurane Market Share Forecast by Country (2027-2032) Table 126. Latin America Sevoflurane Market Size Growth Rate (CAGR) by Country (K t): 2021 VS 2025 VS 2032 Table 127. Latin America Sevoflurane Sales by Country (2021-2026) & (K t) Table 128. Latin America Sevoflurane Sales Market Share by Country (2021-2026) Table 129. Latin America Sevoflurane Sales Forecast by Country (2027-2032) & (K t) Table 130. Latin America Sevoflurane Sales Market Share Forecast by Country (2027-2032) Table 131. Latin America Sevoflurane Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Latin America Sevoflurane Market Size by Country (2021-2026) & (US$ Million) Table 133. Latin America Sevoflurane Market Share by Country (2021-2026) Table 134. Latin America Sevoflurane Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Latin America Sevoflurane Market Share Forecast by Country (2027-2032) Table 136. Middle East and Africa Sevoflurane Market Size Growth Rate (CAGR) by Country (K t): 2021 VS 2025 VS 2032 Table 137. Middle East and Africa Sevoflurane Sales by Country (2021-2026) & (K t) Table 138. Middle East and Africa Sevoflurane Sales Market Share by Country (2021-2026) Table 139. Middle East and Africa Sevoflurane Sales Forecast by Country (2027-2032) & (K t) Table 140. Middle East and Africa Sevoflurane Sales Market Share Forecast by Country (2027-2032) Table 141. Middle East and Africa Sevoflurane Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Middle East and Africa Sevoflurane Market Size by Country (2021-2026) & (US$ Million) Table 143. Middle East and Africa Sevoflurane Market Share by Country (2021-2026) Table 144. Middle East and Africa Sevoflurane Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Middle East and Africa Sevoflurane Market Share Forecast by Country (2027-2032) Table 146. Key Raw Materials Table 147. Raw Materials Key Suppliers Table 148. Sevoflurane Distributors List Table 149. Sevoflurane Customers List Table 150. Research Programs/Design for This Report Table 151. Authors List of This Report Table 152. Secondary Sources Table 153. Primary Sources List of Figures Figure 1. Sevoflurane Image Figure 2. Global Sevoflurane Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Sevoflurane Market Size (2021-2032) & (US$ Million) Figure 4. Global Sevoflurane Sales (2021-2032) & (K t) Figure 5. Generic Drug Image Figure 6. Global Generic Drug Sales YoY Growth (2021-2032) & (K t) Figure 7. Original Drug Image Figure 8. Global Original Drug Sales YoY Growth (2021-2032) & (K t) Figure 9. Global Sevoflurane Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Sevoflurane Market Share by Type 2025 VS 2032 Figure 11. North America Sevoflurane Sales Market Share in Volume by Type in 2025 Figure 12. North America Sevoflurane Sales Market Share in Value by Type in 2025 Figure 13. Europe Sevoflurane Sales Market Share in Volume by Type in 2025 Figure 14. Europe Sevoflurane Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Sevoflurane Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Sevoflurane Sales Market Share in Value by Type in 2025 Figure 17. Latin America Sevoflurane Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Sevoflurane Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Sevoflurane Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Sevoflurane Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Sevoflurane Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospitals Image Figure 24. Global Hospitals Sales YoY Growth (2021-2032) & (K t) Figure 25. Other Medical Institutions Image Figure 26. Global Other Medical Institutions Sales YoY Growth (2021-2032) & (K t) Figure 27. Global Sevoflurane Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Sevoflurane Market Share by Application 2025 VS 2032 Figure 29. North America Sevoflurane Sales Market Share in Volume by Application in 2025 Figure 30. North America Sevoflurane Sales Market Share in Value by Application in 2025 Figure 31. Europe Sevoflurane Sales Market Share in Volume by Application in 2025 Figure 32. Europe Sevoflurane Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Sevoflurane Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Sevoflurane Sales Market Share in Value by Application in 2025 Figure 35. Latin America Sevoflurane Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Sevoflurane Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Sevoflurane Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Sevoflurane Sales Market Share in Value by Application in 2025 Figure 39. North America Sevoflurane Sales by Country: 2021 VS 2025 VS 2032 (K t) Figure 40. North America Sevoflurane Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Sevoflurane Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Sevoflurane Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Sevoflurane Sales by Country: 2021 VS 2025 VS 2032 (K t) Figure 44. Europe Sevoflurane Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Sevoflurane Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Sevoflurane Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Sevoflurane Sales by Country: 2021 VS 2025 VS 2032 (K t) Figure 48. Asia-Pacific Sevoflurane Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Sevoflurane Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Sevoflurane Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Sevoflurane Sales by Country: 2021 VS 2025 VS 2032 (K t) Figure 52. Latin America Sevoflurane Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Sevoflurane Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Sevoflurane Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Sevoflurane Sales by Country: 2021 VS 2025 VS 2032 (K t) Figure 56. Middle East and Africa Sevoflurane Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Sevoflurane Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Sevoflurane Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Sevoflurane Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Sevoflurane Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Generic Drug
  • Original Drug
Applications
  • Hospitals
  • Other Medical Institutions
Companies covered
  • Abbott
  • Baxter
  • Maruishi
  • Jiangsu Hengrui
  • Lunan

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Sevoflurane Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Sevoflurane Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Sevoflurane Market by Type
  6. 1.3.1 Generic Drug
  7. 1.3.2 Original Drug
  8. 1.4 Global Sevoflurane Market Size by Type
  9. 1.4.1 Global Sevoflurane Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Sevoflurane Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Sevoflurane Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Sevoflurane Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Sevoflurane Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Sevoflurane Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Sevoflurane Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Sevoflurane Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Sevoflurane Industry Trends
  2. 2.2 Sevoflurane Industry Drivers
  3. 2.3 Sevoflurane Industry Opportunities and Challenges
  4. 2.4 Sevoflurane Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Sevoflurane Revenue (2021-2026)
  2. 3.2 Global Top Players by Sevoflurane Sales (2021-2026)
  3. 3.3 Global Top Players by Sevoflurane Price (2021-2026)
  4. 3.4 Global Sevoflurane Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Sevoflurane Major Company Production Sites & Headquarters
  6. 3.6 Global Sevoflurane Company, Product Type & Application
  7. 3.7 Global Sevoflurane Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Sevoflurane Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Sevoflurane Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Sevoflurane Tier 1, Tier 2, and Tier 3
4 Sevoflurane Regional Status and Outlook
  1. 4.1 Global Sevoflurane Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Sevoflurane Historic Market Size by Region
  3. 4.2.1 Global Sevoflurane Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Sevoflurane Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Sevoflurane Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Sevoflurane Forecasted Market Size by Region
  7. 4.3.1 Global Sevoflurane Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Sevoflurane Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Sevoflurane Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Sevoflurane by Application
  1. 5.1 Sevoflurane Market by Application
  2. 5.1.1 Hospitals
  3. 5.1.2 Other Medical Institutions
  4. 5.2 Global Sevoflurane Market Size by Application
  5. 5.2.1 Global Sevoflurane Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Sevoflurane Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Sevoflurane Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Sevoflurane Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Sevoflurane Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Sevoflurane Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Sevoflurane Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Sevoflurane Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Abbott
  2. 6.1.1 Abbott Company Information
  3. 6.1.2 Abbott Business Overview
  4. 6.1.3 Abbott Sevoflurane Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Abbott Sevoflurane Product Portfolio
  6. 6.1.5 Abbott Recent Developments
  7. 6.2 Baxter
  8. 6.2.1 Baxter Company Information
  9. 6.2.2 Baxter Business Overview
  10. 6.2.3 Baxter Sevoflurane Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Baxter Sevoflurane Product Portfolio
  12. 6.2.5 Baxter Recent Developments
  13. 6.3 Maruishi
  14. 6.3.1 Maruishi Company Information
  15. 6.3.2 Maruishi Business Overview
  16. 6.3.3 Maruishi Sevoflurane Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Maruishi Sevoflurane Product Portfolio
  18. 6.3.5 Maruishi Recent Developments
  19. 6.4 Jiangsu Hengrui
  20. 6.4.1 Jiangsu Hengrui Company Information
  21. 6.4.2 Jiangsu Hengrui Business Overview
  22. 6.4.3 Jiangsu Hengrui Sevoflurane Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Jiangsu Hengrui Sevoflurane Product Portfolio
  24. 6.4.5 Jiangsu Hengrui Recent Developments
  25. 6.5 Lunan
  26. 6.5.1 Lunan Company Information
  27. 6.5.2 Lunan Business Overview
  28. 6.5.3 Lunan Sevoflurane Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Lunan Sevoflurane Product Portfolio
  30. 6.5.5 Lunan Recent Developments
7 North America by Country
  1. 7.1 North America Sevoflurane Sales by Country
  2. 7.1.1 North America Sevoflurane Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Sevoflurane Sales by Country (2021-2026)
  4. 7.1.3 North America Sevoflurane Sales Forecast by Country (2027-2032)
  5. 7.2 North America Sevoflurane Market Size by Country
  6. 7.2.1 North America Sevoflurane Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Sevoflurane Market Size by Country (2021-2026)
  8. 7.2.3 North America Sevoflurane Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Sevoflurane Sales by Country
  2. 8.1.1 Europe Sevoflurane Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Sevoflurane Sales by Country (2021-2026)
  4. 8.1.3 Europe Sevoflurane Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Sevoflurane Market Size by Country
  6. 8.2.1 Europe Sevoflurane Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Sevoflurane Market Size by Country (2021-2026)
  8. 8.2.3 Europe Sevoflurane Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Sevoflurane Sales by Country
  2. 9.1.1 Asia-Pacific Sevoflurane Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Sevoflurane Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Sevoflurane Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Sevoflurane Market Size by Country
  6. 9.2.1 Asia-Pacific Sevoflurane Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Sevoflurane Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Sevoflurane Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Sevoflurane Sales by Country
  2. 10.1.1 South America Sevoflurane Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Sevoflurane Sales by Country (2021-2026)
  4. 10.1.3 South America Sevoflurane Sales Forecast by Country (2027-2032)
  5. 10.2 South America Sevoflurane Market Size by Country
  6. 10.2.1 South America Sevoflurane Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Sevoflurane Market Size by Country (2021-2026)
  8. 10.2.3 South America Sevoflurane Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Sevoflurane Sales by Country
  2. 11.1.1 Middle East and Africa Sevoflurane Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Sevoflurane Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Sevoflurane Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Sevoflurane Market Size by Country
  6. 11.2.1 Middle East and Africa Sevoflurane Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Sevoflurane Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Sevoflurane Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Sevoflurane Value Chain Analysis
  2. 12.1.1 Sevoflurane Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Sevoflurane Production Mode & Process
  7. 12.2 Sevoflurane Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Sevoflurane Distributors
  10. 12.2.3 Sevoflurane Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst